Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Female ddY mice show a weaker diazepam-induced reduction in aggressive biting behavior toward inanimate objects and lower hypothalamic KCC2 expression than males do
Kento Igarashi; Satoshi Kuchiiwa; Toshiko Kuchiiwa; Kazuo Tomita; Tomoaki SatoShow moreShow less
Department of Applied Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan; Department of Morphological Science, Field of Neurology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan; Department of Clinical Psychology, Graduate School of Human Science, Kagoshima Immaculate Herat University, 2365 Amatatsu-Cho, Satsuma-Sendai, 895-0011, JapanShow moreShow less
Ligand-specific effects of 5-HT2A receptor antagonists on fear extinction in C57BL/6J mice: Comparative insights from MDL 11,939 and MDL 100,907
Anastasia Tyulmenkova; Robert W. StackmanShow moreShow less
Department of Biological Sciences, Charles E. Schmidt College of Science, Florida Atlantic University, Jupiter, FL, 33458, USA; Department of Psychology, Charles E. Schmidt College of Science, Florida Atlantic University, Jupiter, FL, 33458, USAShow moreShow less
3,4-Dimethoxyacetophenone ameliorates epileptogenesis by suppressing BDNF, c-fos, and JAK-2/ STAT-3 expression in a pentylenetetrazole-induced kindling model of epilepsy
Sadia Basharat Ali; Muhammad Jamal; Maria Ayub; Uzair Nisar; Saima Mahmood Malhi; Shaheen Faizi; Shabana Usman Simjee; Marcello IritiShow moreShow less
Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, Faculty of Sciences, University of Karachi, Karachi, 75270, Pakistan; H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Faculty of Sciences, University of Karachi, Karachi, 75270, Pakistan; Faculty of Pharmacy, University of Chakwal, Chakwal, Pakistan; Department of Pharmacology, Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan; Dow College of Pharmacy, Faculty of Pharmaceutical Sciences, Dow University of Health Sciences, Karachi, Pakistan; Department of Biomedical, Surgical and Dental Sciences, University of Milan, via Luigi Vanvitelli 32, Milan, 20129, Italy; National Interuniversity Consortium of Materials Science and Technology (INSTM), 50121, Firenze, ItalyShow moreShow less
The GLP-1 receptor agonist semaglutide reduces alcohol consumption and anxiety-like behaviors during withdrawal in Marchigian Sardinian alcohol-preferring rats
Michela Palmisano; Hela Mrizak; Angela E. Gonzalez; Celsey M. St Onge; Chloe M. Erikson; Bryan Cruz; Annabelle Flores-Bonilla; Roman Vlkolinsky; Oleksandr Sharlai; Jessica Benedict; Michal Bajo; Lorenzo Leggio; Roberto Ciccocioppo; Marisa RobertoShow moreShow less
Department of Translational Medicine, The Scripps Research Institute, La Jolla, CA, USA; School of Pharmacy, Center for Neuroscience, Pharmacology Unit, University of Camerino, Italy; Department of Pharmacology, Addiction Science, and Toxicology, The University of Tennessee Health Science Center, Memphis, TN, USA; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program (NIDA IRP) and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research (NIAAA DICBR), NIH, Baltimore and Bethesda, Maryland, USAShow moreShow less
Inhibition of the sphingosine-1-phosphate receptor 1 (S1PR1) as a therapeutic target for aromatase inhibitor-induced musculoskeletal symptoms in mice
Sara M. Herz; Abrar M. Khan; Isis Betancourt-Toscano; Caleb G. Tiron; Viviane N. Ton; Dana E. Selley; M. Imad DamajShow moreShow less
Department of Pharmacology/Toxicology, Virginia Commonwealth University, Richmond, VA, USA; Translational Research Initiative for Pain and Neuropathy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USAShow moreShow less
Targeting the AMPK/SIRT1-NLRP3 inflammasome axis: Simvastatin, Ezetimibe, and their combination attenuate 3-nitropropionic acid-induced striatal neurodegeneration in rats
Abobakr M. Rezqallah; Eman M. Raafat; Shahira NofalShow moreShow less
Pharmacology and Toxicology Department, Faculty of Pharmacy, Capital University (Formerly Helwan University), Ein Helwan, EgyptShow moreShow less
FAQ
How long does NEUROPHARMACOLOGY take to review a manuscript?
As of 2026-11-13, CrushSCI has 15 complete review records for NEUROPHARMACOLOGY. The fastest paper went from submission to acceptance in 16 days (Subunit-specific roles of NR2A and NR2B in the trigeminal ganglion contribute to orofacial neuropathic pain via distinct molecular cascades, received 2026-08-08, accepted 2026-08-24); the slowest took 427 days. The average is 122.9 days and the median is 86 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
